Found: 5
Select item for more details and to access through your institution.
Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): Results of a phase II study.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 7, p. 1384, doi. 10.1002/cncr.22532
- By:
- Publication type:
- Article
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 12, p. 2664
- By:
- Publication type:
- Article
Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0163276
- By:
- Publication type:
- Article
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).
- Published in:
- Comparative Hepatology, 2004, v. 3, p. 1, doi. 10.1186/1476-5926-3-3
- By:
- Publication type:
- Article
LCR1 and LCR2, two multi‐analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 3, p. 308, doi. 10.1111/apt.15082
- By:
- Publication type:
- Article